Table 3.

Recoveries and matrix effects of 5 compounds (n = 3).

Compounds	Concentration (ng/mL)	Recovery		Matrix effect
		Mean ± SD (%)	RSD (%)	Mean ± SD (%)	RSD (%)
Geniposidic acid	10	96.7 ± 4.8	4.96	114 ± 10	8.77
	30	110 ± 13	11.82	103 ± 10	9.71
	300	111 ± 6	5.41	110 ± 4	3.64
	3000	97.8 ± 4.1	4.19	115 ± 2	1.74
Genipin-1-β-gentiobioside	10	97.2 ± 5.5	5.66	92.5 ± 7.5	8.11
	30	94.7 ± 2.1	2.22	114 ± 4	3.51
	300	100 ± 12	12.01	88.6 ± 5.7	6.43
	3000	94.8 ± 4.1	4.32	93.9 ± 4.7	5.01
Geniposide	10	97.4 ± 9.4	9.65	97.3 ± 11.5	11.82
	30	110 ± 4	3.64	96.4 ± 3.7	3.84
	300	84.3 ± 4.0	4.74	106 ± 6.6	6.23
	3000	104 ± 3	2.88	111 ± 6	5.41
Genipin	10	81.2 ± 11.0	13.55	106 ± 9	8.49
	30	81.0 ± 7.4	9.14	115 ± 2	1.74
	300	111 ± 11	9.91	104 ± 9	8.65
	3000	114 ± 5	4.39	92.9 ± 5.2	5.60
Crocetin	10	103 ± 8.	7.77	89.1 ± 4.2	4.71
	30	95.8 ± 10.0	10.44	94.3 ± 6.8	7.21
	300	99.2 ± 13.4	13.51	98.0 ± 13.2	13.47
	3000	98.5 ± 10.0	10.15	98.3 ± 5.4	5.49